Skip to main content

Acute Intracranial Hemorrhage clinical trials at UC Irvine

1 research study open to eligible people

Showing trials for
  • Trial of Andexanet in ICH Patients Receiving an Oral FXa Inhibitor

    open to eligible people ages 18-89

    Randomized, controlled clinical trial evaluating the efficacy and safety of andexanet versus usual standard of care in patients with intracranial hemorrhage anticoagulated with a direct oral anticoagulant

    Orange, California and other locations

Last updated: